You just read:

Zydelig (idelalisib; Gilead) Drug Overview 2019: An Oral, Highly Selective Inhibitor of the Phosphoinositide 3-Kinase (PI3K) Isoform p110-delta

News provided by

Research and Markets

Jul 12, 2019, 19:00 ET